Increased prevalence rate of metabolic syndrome is an independent predictor of cardiovascular disease in patients with antineutrophil cytoplasmic antibody-associated vasculitis.
Soo Bin LeeHyeok Chan KwonMi Il KangYong-Beom ParkJun Yong ParkSang-Won LeePublished in: Rheumatology international (2021)
The prevalence of MetS at diagnosis in all or nonobese AAV patients was significantly higher than those in all or nonobese controls. Furthermore, both BVAS and MetS at diagnosis increased the risk of CVD in nonobese AAV patients.